NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
ID: 343046Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343046

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-029.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)." This initiative aims to support exploratory research that investigates the neurocognitive effects of structural racism on substance use disorder trajectories, particularly focusing on health disparities affecting minority populations. The funding opportunity is part of NIDA's Racial Equity Initiative and emphasizes community engagement, diversity, and inclusion in research efforts. Interested applicants from eligible minority-serving institutions must submit their proposals by November 14, 2024, and can find additional information and application details at the provided NIH link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    RFA-DA-23-029-Full-Announcement.html
    RFA-DA-23-029.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and specifically the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at exploring the neurocognitive mechanisms linked to structural racism and its effects on substance use disorder (SUD) trajectories. This initiative invites clinical research applications from minority-serving institutions to address health disparities related to substance use. The goal is to investigate the complex interplay between structural racism and neurocognition to inform preventative interventions against SUD. The funding opportunity has a phased award mechanism, allowing for up to five years of support, with an initial R61 phase focused on exploratory research leading to a possible R33 phase for expanded study. Eligible organizations include institutions that educate underrepresented populations and that have received limited prior NIH funding. The announcement emphasizes community engagement in research, the need for a Plan for Enhancing Diverse Perspectives, and adherence to NIH’s policies on inclusion and diversity. This funding is part of NIDA’s overarching Racial Equity Initiative, reflecting a commitment to promote racial equity in research, reduce health disparities, and improve the health of minority populations affected by substance use-related issues.
    Similar Opportunities
    NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity titled "Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional)." This initiative aims to support exploratory and developmental research that investigates how structural racism influences substance use trajectories, with a focus on reducing the risk of substance use disorders and informing preventive strategies. The program encourages a multidisciplinary approach, integrating fields such as neuroscience, epidemiology, and sociology, while promoting community-engaged research methods to enhance racial equity. Interested applicants can apply for funding up to $500,000 for the initial R61 phase, with a total anticipated funding of $1.5 million annually for multiple awards. The application deadline is November 14, 2024, and further details can be found at the provided NIH link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions." This initiative invites R01 applications aimed at conducting impactful research to address disparities in substance use and addiction outcomes among racial and ethnic minority populations, emphasizing community engagement and collaboration with community organizations. The program is part of NIDA's broader Racial Equity Initiative, which seeks to improve health equity and reduce health disparities, with approximately $2 million anticipated for funding across multiple related announcements. Interested applicants, particularly from minority-serving institutions, must submit proposals by November 14, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering the Racial Equity Visionary Award Program to support innovative research addressing substance use disparities among underserved racial and ethnic minority groups. This funding opportunity invites early career and established scholars from domestic minority-serving institutions to submit proposals that challenge existing scientific paradigms and aim for transformative impacts in health equity. NIDA plans to allocate approximately $2 million annually for 2-3 awards, with each application budget capped at $700,000 for projects lasting up to five years. Interested applicants must adhere to NIH guidelines and submit their proposals by November 14, 2024, with further inquiries directed to OERWebmaster03@od.nih.gov.
    NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research," aimed at supporting R01 applications that focus on community-partnered research to mitigate disparities in substance misuse and health outcomes among racial and ethnic minority populations. This initiative emphasizes the establishment of collaborative community partnerships to ensure that research addresses immediate community needs and employs effective methodologies, thereby advancing health equity in the context of substance use and addiction. The program has a budget of approximately $2 million for FY 2023, with applications due by November 14, 2024. Interested applicants can find more information and application instructions at the provided link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities," aimed at supporting intervention research to improve health outcomes among minority populations affected by health disparities. The initiative seeks projects that investigate the influence of structural racism and discrimination on health determinants, promote multidisciplinary collaboration, and utilize diverse data sources for comprehensive analysis. With a funding ceiling of $500,000, the application deadline is set for January 7, 2026, and interested applicants can find more information and submission guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity, aimed at supporting innovative research that addresses disparities in substance use among underserved racial and ethnic minority groups in the U.S. This initiative invites applications from early career or established scholars who propose high-impact projects that challenge existing paradigms and foster community engagement to tackle systemic factors impacting health disparities. With a funding commitment of approximately $2 million annually for 2-3 awards, applicants can request up to $700,000 in direct costs per year for a maximum project period of five years. Interested applicants should submit their proposals by November 14, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. For more details, visit the official announcement at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-026.html.
    NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and ethnic populations. This initiative seeks to stimulate research that explores structural, organizational, and contextual factors contributing to these inequities, with a focus on complex identities and social systems affecting marginalized communities. A total funding pool of $3 million is anticipated for 5-9 awards, with applications due by November 14, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R34 Planning Grant under its Racial Equity Initiative (REI), aimed at addressing HIV-related health disparities among underserved racial and ethnic populations. This funding opportunity supports pilot or feasibility research that explores the social, structural, and contextual factors contributing to inequities at the intersection of HIV and substance use, while encouraging projects that consider individuals' multidimensional identities. The initiative is critical in promoting health equity and aligns with the HHS's goal of ending the HIV epidemic by 2030, with a total budget of $3 million available to fund 5 to 9 projects, each with direct cost requests up to $450,000 over three years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by November 14, 2024.
    Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Exploratory Clinical Neuroscience Research on Substance Use Disorders" (R61/R33), aimed at supporting innovative clinical research that explores the neurobiological mechanisms underlying substance use disorders (SUD). This initiative encourages applications that investigate neural circuitry and cognitive processes affecting substance use behavior, particularly in the context of the ongoing public health crisis related to SUDs, including the opioid epidemic. The R61/R33 mechanism allows for up to five years of funding, divided into an initial two-year R61 phase and a potential three-year R33 phase, contingent upon meeting specified milestones. Interested applicants can find more information and submit proposals by the application due date of March 13, 2026, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Providing Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and Addiction Scientific Workforce (R25 Clinical Trials Not Allowed)." This initiative aims to support educational activities that promote diversity in the biomedical and behavioral sciences, particularly focusing on substance use and addiction research, by encouraging applications from institutions committed to underrepresented groups. The program seeks to develop a diverse pool of researchers through mentorship and educational activities tailored to various career stages, with a budget request limit of $250,000 in direct costs annually for up to five years. Interested applicants must submit their proposals by 5:00 PM local time on November 13, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.